Skip to Main Content

KOR Medical

  • sam patrick posted an article
    South Carolina Company Offers Free Personalized Support to Purchasers see more

    Charleston-based health innovation company KOR Medical --which produces unique cannabinoid products designed to support physical and mental wellness through expert engineering coupled with an individualized approach -- launches its initial consumer product line of CBD, CBN and CBG product offerings across the United States today.

    To celebrate its nationwide launch, KOR is offering up to 30% off the valued price of its KOR System Bundle – a curated collection of Health, Sleep, Calm and Relief sprays, strips, and transdermal cream. The special can be purchased 24/7 online at www.KORmedical.com by using discount code LAUNCHDEAL at checkout. Shipping is included on each KOR System bundle, and consumers can also order KOR products individually.

    Aligning biology with science, KOR’s long-awaited and third-party tested Health, Sleep, Calm and Relief products include sprays, strips and transdermal cream which use a combination of various cannabinoids and advanced delivery techniques developed over years of research, analytics and testing to help consumers feel better both mentally and physically.

    Citing the mental and physical strain on American consumers of the last two years, KOR Medical products utilize the transformative power of cannabinoids to support mental and physical wellness by delivering the right amount for the right individual at the right time. Consumers across America are embracing cannabinoids given their potential as an alternative solution.

    KOR Medical has partnered with Leaf411™ to provide free, personalized support to customers, who can speak directly with a cannabis-trained registered nurse on cannabinoid use and applications.

    KOR Medical’s sublingual sprays, sublingual strips, and transdermal cream are formulated for targeted relief and quick onset. All sublingual products are nano emulsified to accelerate absorption rate within the body.

    All KOR Medical cannabinoid-based product offerings are manufactured in FDA-registered facilities and third-party lab-verified and represent the highest standards of science, innovation, patient experience, compliance, and customer service.

    The cannabis flower has a rich history of usage in the neuropathic industry dating back thousands of years, and produces over 100 cannabinoids including CBN, CBG and CBD – each a key component is KOR Medical products, and with unique benefits and effects. Today, medical researchers are continuing to explore if these molecules can impact anxiety, insomnia, chronic pain, anti-inflammatory diseases, seizures, and such diseases as Alzheimer’s and Parkinson’s disease.

    Visit KOR Medical at www.kormedical.com.

  • sam patrick posted an article
    Life sciences expands career opportunities for SC graduates see more

    Compliments of Lowcountry Graduate Press

    COVID caused pain and heartache and death across the world and here in the Lowcountry, but it also revealed some bright spots. One of those is the life sciences industry, which was responsible for diagnosing COVID, providing responses, and ultimately developing effective vaccines.

    Coincidentally, the life sciences industry in South Carolina is itself on a growth spurt that was accelerated by the pandemic. The number of firms in the industry had doubled in the last four years, making it the fastest-growing industry sector in the state. The Darla Moore School of Business estimated its annual economic impact at $12 billion before the most recent spike.

    Life sciences produce next-generation pharmaceuticals and vaccines; advanced medical devices, diagnostics, and testing; digital health; bioscience distribution; bio-agriculture and biomaterials; and biological solutions for advanced manufacturing.

    Life sciences also encompass two areas of focus for the Lowcountry Graduate Center – advanced manufacturing and healthcare management. While the connection with healthcare is obvious, many people don’t realize that life science research and advanced manufacturing work symbiotically. Many life science innovations, like medical devices, require advanced manufacturing to produce, while life science innovations can power the process of advanced manufacturing itself.

    Career Opportunities in Life Sciences

    That means jobs, and not just for M.D.s and Ph.D.’s, but for technical college graduates and university biology and chemistry majors as well. The average life sciences position pays $79,000, according to the official state affiliate of the U.S. Biotechnology Innovation Organization, also referred to as SCBIO, the nonprofit organization dedicated to promoting the life sciences industry in S.C. Because workforce development is the primary challenge facing the industry, SCBIO is engaged in an initiative to promote the industry as a career path for students, guidance counselors, and parents at the K-12 level and in two- and four-year college.

    Indeed, SCBIO is in the process of developing an industry-advocated life sciences curriculum for technical colleges that can prepare graduates for jobs in the field. Courses would cover manufacturing processes; safety and technical protocols like measurements and ISO standards; soft skills required for all workplaces; and the connections between the various life science components and the life-saving innovations they support.

    “We want to get to students even sooner so we’re partnering with organizations that are already in schools to add more of the ‘S’ in STEM,” said Erin Ford, interim CEO at SCBIO. “If someone takes a course at Trident Tech, they can get a job paying $50,000 or more with health insurance while working on a product that helps people live better lives.”

    The vector of life science development is different depending on the area of the state, with the Lowcountry showing strength in biotechnology, pharmaceutical, and manufacturing, says Ford.

    Life Science Companies Need Space to Grow

    Besides workforce development, the next big challenge constraining growth is space. Lab space at the new WestEdge development in downtown Charleston was fully subscribed when it opened and now developers are seeking new space. Clean labs are more complex and costly to retrofit and build than ordinary office or warehouse space.

    Nonetheless, the firms keep coming – or starting – and the state has gotten behind the industry. As a critical step, it authorized and funded SCBIO as the state’s lead life sciences industry economic development organization.

    Life science provides more than just more job growth: it provides diversification of an economy that 30 years ago relied heavily on a Navy base that packed up and left. Life sciences are more recession-resistant than automotive and aeronautics, two areas of manufacturing strength in the Lowcountry that respond to retail market demand. People never cease needing health innovations.

    Recognizing that, the Charleston Regional Development Alliance (CRDA) and South Carolina Research Authority have backed the industry. CRDA was the first development authority in the state to build map out a strategic plan to attract and retain life science businesses.

    Headwinds for Life Sciences in South Carolina

    Sam Konduros of KOR Medical, a clinical cannabis firm launched by the Charleston-based diagnostic and testing company Vikor Scientific, says South Carolina and SCBIO have created a business climate conducive to the industry, and the health care and advanced manufacturing infrastructure have added tailwinds to its development. Citing Vikor’s growth from 45 employees to 450 during COVID, he says recruiting a talented workforce has not been a significant challenge so far. He notes the usual Charleston quality-of-life benefits – weather, beaches, history, and food, in addition to the growing vibrancy of the industry – as recruiting tools have contributed to the success.

    Ford and Konduros see possible headwinds elsewhere for the industry. Roadways and other transportation infrastructure could use improvement, and housing availability and affordability are statewide issues. For example, the state’s franchise tax, now eliminated by 36 states, penalizes early-stage companies successfully raising venture capital before going to market. In an industry that often spends millions to earn FDA approval prior to commercialization, the tax is a burden, they say.

     September 02, 2021
  • sam patrick posted an article
    Former SCBIO exec Sam Konduros to lead KOR Medical see more

    Former SCBIO CEO Sam Konduros named President and Chief Executive Officer

    of new Vikor Scientific health innovation company

     

    CHARLESTON, SOUTH CAROLINA – May 4, 2021 – Continuing its rapid expansion as one of South Carolina’s fastest growing life sciences and healthcare firms, Charleston-headquartered Vikor Scientific announced that it is launching health innovation company KOR Medical “to set a new industry standard in the arena of personalized clinical cannabis to benefit patients afflicted with diseases ranging from epilepsy to cancer, and to help alleviate the nation’s opioid addiction crisis.” 

    According to KOR Medical Managing Partners and Vikor Scientific Co-Founders Scotty Branch and Shea Harrelson, the company is exploring locations nationwide for its initial state-of-the-art, multi-million-dollar operation.  

    “KOR Medical will be a highly innovative organization that will bring a new blueprint and novel value proposition to the national clinical cannabis marketplace, powered by an AI and blockchain supported seed to sale platform,” said Mr. Branch.  “Coupled with a relentless commitment to personalized medicine and rigorous compliance and purity, KOR will focus on providing clinicians with the tools and data they need to support leading-edge treatment protocols for the needs of each unique patient.”

    In addition to former South Carolina Biotechnology Industry Organization (SCBIO) chief executive Sam Konduros, a seasoned business leader and attorney who will serve as president and CEO, KOR Medical is also onboarding four senior executives that bring multi-disciplinary expertise and experience in the clinical cannabis industry – including Joseph Strauss, who will serve as COO and executive vice president.  Mr. Strauss brings more than a decade of immersive experience in the industry across multiple states to KOR, including Oregon, California, Colorado, and Florida.  Other corporate appointees championing sales and marketing, cultivation and innovation, and government and legal affairs will be announced in early Summer. 

    “Mr. Konduros will lead all aspects of the company’s business and serve on the board of directors of both KOR Medical and Vikor Scientific to provide insights regarding the strategic direction of our portfolio of companies as we expand in the US and globally,” said Mr. Branch.  “Sam is the epitome of a world class CEO.  We look forward to watching him execute our mission with the support of an extraordinary executive team who will enable KOR Medical to achieve its vision to help transform healthcare.” 

    Armed with a comprehensive business plan and finalization of its laboratory-grade indoor growing facility design, KOR Medical is currently forging key industry and business partnerships with numerous entities with established track records in the cannabis industry.  KOR Medical expects to confirm its initial US location of operations by mid-Summer 2021, with the site becoming a model for future expansion across the nation.  KOR is planning its initial product launch during 2021, followed by full-scale production in 2022. 

    Visit KOR Medical at www.kormedical.com and Vikor Scientific at www.VikorScientific.com.